Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:516-517

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SoRelle, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SoRelle, R.

(Circulation. 1998;97:516-517.)
© 1998 American Heart Association, Inc.


Cardiovascular News

Report on the American Medical Association Meeting

Ruth SoRelle, Circulation Newswriter

The American Medical Association (AMA) faced an identity crisis at its interim meeting in Dallas. What is the value of its name? What does the name American Medical Association mean? What is the AMA? Is it a moneymaking entity that lobbies for doctors? Or is it a professional association that upholds the ethical standards that are expected of its members?

A contract to endorse Sunbeam products brought the issues to a head. In August, AMA top officials announced the so-called "cobranding" or endorsement contract that would have put the AMA name and logo on consumer medical products. There was no plan to test the products, and it also violated an unwritten 40-year-old rule against product endorsements by the group. The AMA Board of Trustees hastily canceled the contract in September.

In the resulting furor, four top officials of the organization resigned. A week before the AMA interim meeting in Dallas, the AMA's top paid executive, P. John Seward, MD, also resigned after the New Jersey delegation to the meeting introduced a resolution calling for his ouster as well as that of AMA chairman Thomas Reardon, MD.

The AMA committee that heard the complaints of members about the contract during the meeting convened beyond its planned adjournment time as physician after physician lambasted the AMA board and executive staff for selling the organization's name.

Arnold Relman, MD, former editor of the New England Journal of Medicine, was the first speaker, in an unaccustomed appearance before the body. "In my opinion, . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Diabetes CareHome page
A. I. Vinik, T. Erbas, T. S. Park, K. B. Stansberry, J. A. Scanelli, and G. L. Pittenger
Dermal Neurovascular Dysfunction in Type 2 Diabetes
Diabetes Care, August 1, 2001; 24(8): 1468 - 1475.
[Abstract] [Full Text] [PDF]